Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study
单位:[1]China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China[2]Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA[3]Da Qing First Hosp, Dept Cardiol, Da Qing, Peoples R China[4]World Hlth Org, Dept Chron Dis & Hlth Promot, Geneva, Switzerland[5]NIDDKD, Diabet Epidemiol & Clin Res Sect, NIH, Phoenix, AZ USA
We determined the effects of 6 years of lifestyle intervention in persons with impaired glucose tolerance (IGT) on the development of retinopathy, nephropathy and neuropathy over a 20 year period. In 1986, 577 adults with IGT from 33 clinics in Da Qing, China were randomly assigned by clinic to a control group or one of three lifestyle intervention groups (diet, exercise, and diet plus exercise). Active intervention was carried out from 1986 to 1992. In 2006 we conducted a 20 year follow-up study of the original participants to compare the incidence of microvascular complications in the combined intervention group vs the control group. Follow-up information was obtained on 542 (94%) of the 577 original participants. The cumulative incidence of severe retinopathy was 9.2% in the combined intervention group and 16.2% in the control group (p = 0.03, log-rank test). After adjusting for clinic and age, the incidence of severe retinopathy was 47% lower in the intervention group than the control group (hazard rate ratio 0.53, 95% CI 0.29-0.99, p = 0.048). No significant differences were found in the incidence of severe nephropathy (hazard rate ratio 1.05, 95% CI 0.16-7.05, intervention vs control, p = 0.96) or in the prevalence of neuropathy (8.6% vs 9.1%, p = 0.89) among the 20 year survivors. Lifestyle intervention for 6 years in IGT was associated with a 47% reduction in the incidence of severe, vision-threatening retinopathy over a 20 year interval, primarily due to the reduced incidence of diabetes in the intervention group. However, similar benefits were not seen for nephropathy or neuropathy.
基金:
CDC/WHOWorld Health OrganizationUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U58/CCU424123-01-02]; China-Japan Friendship Hospital; Da Qing First Hospital; American Diabetes AssociationAmerican Diabetes Association; National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
第一作者单位:[1]China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China[5]NIDDKD, Diabet Epidemiol & Clin Res Sect, NIH, Phoenix, AZ USA
通讯作者:
推荐引用方式(GB/T 7714):
Gong Q.,Gregg E. W.,Wang J.,et al.Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study[J].DIABETOLOGIA.2011,54(2):300-307.doi:10.1007/s00125-010-1948-9.
APA:
Gong, Q.,Gregg, E. W.,Wang, J.,An, Y.,Zhang, P....&Bennett, P. H..(2011).Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study.DIABETOLOGIA,54,(2)
MLA:
Gong, Q.,et al."Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study".DIABETOLOGIA 54..2(2011):300-307